How states are using the law to bring drug executives to heel
Lawyers and regulators are starting to get tough legally to bring generic drug executives to heel, as evidenced by two federal court lawsuits.
Lawyers and regulators are starting to get tough legally to bring generic drug executives to heel, as evidenced by two federal court lawsuits.
The QuintilesIMS Institute has released a timely report on the global market for medicines, forecasting a slowdown in drug price increases but overall growth to a massive $1.5 trillion by 2021.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The maker of EpiPen, the life-saving auto-injector for anaphylaxis, is under fire for exorbitant price hikes so much so that even Martin Shkreli called Mylan out for price-gouging last week.